RICHLAND, WASH., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR) today announced an executed agreement with MIM Software to deliver a novel one-stop-provides-all program to treat ...
Chicago-based GE HealthCare announced it closed its acquisition of AI and imaging solutions company MIM Software, expanding its digital imaging offerings. Cleveland-based MIM Software provides remote ...
JERUSALEM and CLEVELAND, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Today, Alpha Tau Medical Ltd. (DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and MIM ...
The anticipated acquisition aligns to GE HealthCare’s precision care strategy with the goal of strengthening the company’s digital solutions across care pathways MIM Software provides AI-enabled image ...
As you learned from MobiHealthNews this week, MIM Software received a second FDA 510(k) clearance for its MobileMIM radiology app. In this case, the Food and Drug Administration approved MobileMIM ...
MIM Software, a Cleveland-based company that sells medical imaging analysis and artificial intelligence solutions for radiation oncology, diagnostic imaging and other treatments, has entered an ...
GE HealthCare today announced the launch of its first combined software release with MIM Encore, which the Chicago-based medical imaging giant said would enhance digital imaging and workflow solutions ...
Through the development of Mobile MIM and other new technologies, MIM Software™ has achieved distinction in the medical imaging field and is influential in initiating and driving market standards.
MIM Software's SurePlan™ MRT has quickly become the standard application used for radiopharmaceutical therapy in Centers of Excellence across North America. CLEVELAND, March 29, 2023 /PRNewswire/ -- ...
MIM Software, makers of MIM Mobile, the industry's first FDA-approved radiology viewing app, have turned their attention from physician users to patients. While MIM Mobile mainly was created for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results